Skip to main content
    N

    NextCure  Inc (NXTC)

    Official site

    HEALTHCARE • BIOTECHNOLOGY • NASDAQ

    $6.68
    +0.28 (+4.38%)

    Market Cap: $29.31M

    Last updated: Nov 17, 2026 at 11:05 AM ET

    NextCure  Inc (NXTC) Competitors

    Updated Nov 17, 2026. Similar companies are ranked by business profile, size, sector and industry; metrics come from company filings and market prices.

    The companies most similar to NextCure are INmune Bio (INMB), Plus Therapeutics (PSTV) and CervoMed (CRVO). By market cap, NextCure ranks 6th of the 13 companies on this page; Connect Biopharma Holdings (CNTB) is the largest at $42.65M.

    Peer Comparison

    NXTC's revenue growth of -100.0% is below the peer median of 0.0%. Like the median peer, it pays no dividend.

    CompanyMarket capP/EP/SNet marginROICRev growthDiv yield
    NextCure (NXTC)$29.31MN/AN/A0.0%N/A-100.0%0.00%
    INmune Bio Inc (INMB)$32.51MN/AN/A0.0%N/A257.1%0.00%
    Plus Therapeutics Inc (PSTV)$26.64MN/A2.0x-230.2%-827.8%-2.9%0.00%
    CervoMed Inc. (CRVO)$25.57MN/AN/A0.0%N/A-99.6%0.00%
    CEL-SCI Corp (CVM)$22.51MN/AN/A0.0%-109.0%-62.7%0.00%
    Telomir Pharmaceuticals, Inc. Common Stock (TELO)$36.15MN/AN/A0.0%N/A0.0%0.00%
    NanoViricides Inc (NNVC)$31.41MN/AN/A0.0%N/A0.0%0.00%
    Cocrystal Pharma Inc (COCP)$18.88MN/A39.2x0.0%N/A26.9%0.00%
    Connect Biopharma Holdings Ltd (CNTB)$42.65MN/A13.6x0.0%N/A5667.0%0.00%
    Lite Strategy, Inc. (LITS)$25.30MN/AN/A0.0%N/A0.0%0.00%
    Quince Therapeutics, Inc. (QNCX)$32.27MN/AN/A0.0%N/A0.0%0.00%
    Cyclerion Therapeutics Inc (CYCN)$15.73MN/AN/A0.0%N/A-43.2%0.00%
    Transcode Therapeutics Inc (RNAZ)$22.35MN/AN/A0.0%-412.7%0.0%0.00%
    Peer median$26.10MN/A13.6x0.0%-412.7%0.0%0.00%
    Market data as of Nov 17, 2026. Net margin covers the trailing 12 months, Rev growth compares the latest quarter with a year earlier and Div yield is the forward yield. P/E uses earnings per share for the last 12 months as companies report it, often adjusted, so it can show beside a negative net margin, which uses net income. P/E and P/S show N/A when those earnings or sales are negative or missing, or the multiple is above 1,000x.

    Similar Companies

    These are the 12 companies most similar to NextCure, ranked by how closely their business, size, sector and industry match. All 12 are in one industry, Biotechnology.

    CompanyAboutPeers
    INmune Bio Inc (INMB)
    INmune Bio, Inc., a clinical-stage immunotherapy company, focuses on reprogramming the patient's innate immune system to treat cancer, Alzheimer's disease...
    INMB competitors
    Plus Therapeutics Inc (PSTV)
    Plus Therapeutics, Inc., a clinical-stage pharmaceutical company, focuses on the development, manufacturing...
    PSTV competitors
    CervoMed Inc. (CRVO)
    CervoMed Inc., a clinical-stage biotechnology company, engages in the development and commercialization of drug treatments for neurodegenerative diseases.
    CRVO competitors
    CEL-SCI Corp (CVM)
    CEL-SCI Corporation is dedicated to the research and development of immunotherapy for the treatment of cancer and infectious diseases.
    CVM competitors
    Telomir Pharmaceuticals, Inc. Common Stock (TELO)
    Telomir Pharmaceuticals, Inc., a pre-clinical-stage pharmaceutical company, focuses on the development and commercialization of therapeutic treatment for human...
    TELO competitors
    NanoViricides Inc (NNVC)
    NanoViricides, Inc., a nanobiopharmaceutical company, discovers, develops and markets drugs for the treatment of viral infections.
    NNVC competitors
    Cocrystal Pharma Inc (COCP)
    Cocrystal Pharma, Inc., a biotechnology company, is focused on the discovery and development of antiviral therapeutic treatments for serious and / or chronic...
    COCP competitors
    Connect Biopharma Holdings Ltd (CNTB)
    Connect Biopharma Holdings Limited, a clinical-stage biopharmaceutical company, is focused on the discovery and development of immune modulators...
    CNTB competitors
    Lite Strategy, Inc. (LITS)
    Lite Strategy, Inc. a clinical-stage pharmaceutical company, focuses on the development of various therapies for the treatment of cancer.
    LITS competitors
    Quince Therapeutics, Inc. (QNCX)
    Quince Therapeutics, Inc., a biopharmaceutical company, is focused on advancing precision therapies for rare and debilitating diseases.
    Cyclerion Therapeutics Inc (CYCN)
    Cyclerion Therapeutics, Inc., a clinical-stage biopharmaceutical company, is dedicated to the discovery, development...
    Transcode Therapeutics Inc (RNAZ)
    TransCode Therapeutics, Inc., a biopharmaceutical company, is dedicated to the development and commercialization of drugs for the treatment of metastatic...
    RNAZ competitors

    Frequently Asked Questions About NXTC

    Who are NextCure's main competitors?

    The companies most similar to NextCure include INmune Bio (INMB), Plus Therapeutics (PSTV), CervoMed (CRVO), CEL-SCI (CVM) and Telomir Pharmaceuticals, Inc. Common Stock (TELO), listed from the closest match.

    Who is NextCure's biggest competitor?

    Connect Biopharma Holdings (CNTB) is the largest of the similar companies at $42.65M; INmune Bio (INMB) is the closest match by business profile, size, sector and industry.

    How does NXTC stock compare with its competitors?

    NXTC's net margin is 0.0% against a peer median of 0.0%.

    Which of NextCure's competitors pays a higher dividend?

    NextCure pays no dividend. None of the similar companies with available yields has a higher forward dividend yield.

    Is NextCure bigger than its competitors?

    No. NextCure is 6th by market cap among the 13 companies on this page; the largest is Connect Biopharma Holdings (CNTB) at $42.65M.